<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>李进医生团队 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-30T20:26:49+08:00</updated>
  <subtitle>科普宣传，患者教育。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CAR-T细胞免疫疗法 ——肿瘤患者新生的希望</title>
    <updated>2020-12-30T16:57:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/tJ8BNHlwkIDywpuCwUMlGQ</id>
    <link href="https://mp.weixin.qq.com/s/tJ8BNHlwkIDywpuCwUMlGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鼎力创新，共泽生命 | 秦叔逵教授、李进教授：共同推进我国抗肿瘤创新药物研发，助力健康中国建设</title>
    <updated>2020-12-29T16:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/o5y24t4KR42BXqBvKwOvew</id>
    <link href="https://mp.weixin.qq.com/s/o5y24t4KR42BXqBvKwOvew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤营养系列一：治疗前和治疗期间的营养支持</title>
    <updated>2020-12-25T16:49:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/9gDXp4UHXsr8XNhiRtgGYQ</id>
    <link href="https://mp.weixin.qq.com/s/9gDXp4UHXsr8XNhiRtgGYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁晓华教授：肺癌脑转移患者所关注的治疗相关疑问解答（下）</title>
    <updated>2020-12-24T17:17:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/qbxAkgqxLP4H_TI3uhxqIQ</id>
    <link href="https://mp.weixin.qq.com/s/qbxAkgqxLP4H_TI3uhxqIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>帕博利珠单抗获批头颈鳞癌一线治疗适应症，郭晔教授开出首张处方</title>
    <updated>2020-12-22T15:56:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/RGZe0A9uypzUUNcMT0N7wg</id>
    <link href="https://mp.weixin.qq.com/s/RGZe0A9uypzUUNcMT0N7wg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁晓华教授：肺癌脑转移患者所关注的治疗相关疑问解答（中）</title>
    <updated>2020-12-17T17:07:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/iJ-WLpnCtIQff0wBG-MFhA</id>
    <link href="https://mp.weixin.qq.com/s/iJ-WLpnCtIQff0wBG-MFhA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谈笑间丨殷咏梅教授：待患者以柔，待学子以博、善，初心未改，有暗香来</title>
    <updated>2020-12-15T16:51:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/-14SEMohMb9on8kJYiOzOg</id>
    <link href="https://mp.weixin.qq.com/s/-14SEMohMb9on8kJYiOzOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>K药“首”领一线, 第六个适应证头颈部鳞癌正式获批, 带来4年生存率突破性改善</title>
    <updated>2020-12-11T16:23:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/O-1mli7OR2ODbc9hiTOjxA</id>
    <link href="https://mp.weixin.qq.com/s/O-1mli7OR2ODbc9hiTOjxA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>梁晓华教授：肺癌脑转移患者所关注的治疗相关疑问解答（上）</title>
    <updated>2020-12-10T16:44:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/enQdllrDcnfgsxnUK645Rg</id>
    <link href="https://mp.weixin.qq.com/s/enQdllrDcnfgsxnUK645Rg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谈笑间丨医之大者，为国为民——马军教授：从一穷二白到世界前沿，栉风沐雨五十载，终不负“医生”之名</title>
    <updated>2020-12-07T17:02:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/ykLGf99NmywMfCp9AE7zUA</id>
    <link href="https://mp.weixin.qq.com/s/ykLGf99NmywMfCp9AE7zUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>